Results 251 to 260 of about 706,480 (354)

Report of the FDA's expert panel on hormone therapy. [PDF]

Menopause
Pinkerton JV, Simon JA, Hodis HN, Minkin MJ, Manson JE, Levy B.   +5 more
europepmc   +1 more source

Living at genetic risk: The patient experience of Lynch syndrome

International Journal of Cancer, EarlyView.
Abstract Lynch syndrome is a germline cancer predisposition syndrome caused by a variant in one of four genes. Lynch syndrome places individuals at significantly higher risk for a range of cancers, especially colorectal and endometrial. Depending on which gene is affected, the risk of ovarian, gastric, small bowel, pancreatic, biliary urothelial, brain,
Nicola Reents, Georgina Hoffmann, Kelly Kohut   +2 more
wiley   +1 more source

First report of a combined hemostatic technique using Hydrofit® and SURGICEL Absorbable HemostatTM for intraoperative hemorrhage in gynecologic oncology surgery: a video article. [PDF]

Obstet Gynecol Sci
Ijichi K, Nakahara M, Nakahara Y, Fujiyama K, Kaya S, Kuki S, Nagasawa S, Ito Y, Maruyama Y, Ogishima D.   +9 more
europepmc   +1 more source

A multilevel perspective on MSH6‐associated Lynch syndrome: Integrating molecular, biological, and clinical insights

International Journal of Cancer, EarlyView.
Abstract Lynch syndrome (LS) is the most common hereditary colorectal cancer syndrome, caused by a germline pathogenic variant in one of the mismatch repair (MMR) genes. Among these, MSH6‐associated LS represents a distinct subtype with unique molecular and clinical characteristics.
Salwa Ben Yahia, Anne‐Sophie van der Werf‐'t Lam, Madalina Cabuta, Maartje Nielsen, Noah C. Helderman   +4 more
wiley   +1 more source

Perceptions of Patients and Physicians Regarding Audio-Only Gynecology Virtual Clinics: The Experience of a Tertiary Hospital in Jeddah, Saudi Arabia. [PDF]

Cureus
Khalil AM, Alharazi SS, Bakhamees FH.
europepmc   +1 more source

Follow‐Up and Outcomes After Thermal Ablation Treatment Among HIV‐Infected Women From Resource‐Limited Countries With Positive HPV‐Based Screening: Results of the AIMA‐CC Cohort (ANRS 12375)

International Journal of Cancer, EarlyView.
ABSTRACT Primary screening for human papillomavirus (HPV) followed by treatment with thermal ablation (TA) is an important component of the global strategy to eliminate cervical cancer. However, evidence on post‐TA outcomes in women living with HIV (WLWH) remains limited.
Pierre Debeaudrap, Firmin Nongodo Kabore, Limsreng Setha, Joseph Tegbe, Brahima Doukoure, Moeung Sotheara, Olivier Segeral, Korn Aun, Eugène Messou, Matthieu Chicaud, Kim Sothea, Pierre Vassilakos, Armel Poda, Evelyne Kasilé Poda, Antoine Jaquet, Adolphe Some, Patrick Petignat, Gary Clifford, Apollinaire Horo   +18 more
wiley   +1 more source

Robotic Transvaginal Sacrocolpopexy via SHURUI Single-port Snake-arm System. [PDF]

Gynecol Minim Invasive Ther
Zhang C, Huang Q, Basinda MS, Guan X.
europepmc   +1 more source

Value of Axillary Palpation and Ultrasound, and Axillary Recurrence in Male Breast Cancer: Results of the Registry Study

International Journal of Cancer, EarlyView.
ABSTRACT Clinical and sonographic examination of breasts and axillae is standard in breast cancer (BC) care. The aim of this study is to highlight the value of axillary ultrasound in identifying axillary recurrences in male BC, which is still little considered in the literature.
Monika Graeser, Susen Bothin, Oleg Gluz, Mathias Warm, Atanas Ignatov, Holm Eggemann   +5 more
wiley   +1 more source

Content Validity of a Patient-Reported Measure of Postoperative Recovery. [PDF]

Urogynecology (Phila)
Mueller MG, Ganz MG, Siddiqui NY, Sung V, Andy U, Menefee S, Dounoucos V, Griffith JW, Schaffer J, Mazloomdoost D, Kenton K, Pelvic Floor Disorders Network.   +11 more
europepmc   +1 more source

Global Real‐World Outcomes of Olaparib in Metastatic Castration‐Resistant Prostate Cancer Patients With Homologous Recombination Repair Alterations

International Journal of Cancer, EarlyView.
ABSTRACT Evidence to guide the treatment for patients with metastatic castration‐resistant prostate cancer (mCRPC) and Homologous Recombination Repair (HRR) gene alterations outside of clinical trials remains limited. This was an observational, cohort study, including mCRPC patients with tumor harboring HRR alterations, progressed on a prior androgen ...
Lorena Incorvaia, Daniele Santini, Marc R. Matrana, Marco Maruzzo, Ray Manneh Kopp, Lorenzo Antonuzzo, Sergio Bracarda, Deniz Tural, Giuseppe Procopio, Maria T. Bourlon, Orazio Caffo, Martin Ignacio Zapata Laguado, Massimo Di Maio, Brigida Anna Maiorano, Vincenza Conteduca, Sabrina Rossetti, Helga Lipari, Thomas Büttner, Mimma Rizzo, Yüksel Ürün, Carlo Messina, Fernando Sabino Marques Monteiro, Andrey Soares, Mattia Puglisi, Alice Principi, Eleonora Lai, Giulia Mammone, Marco Stellato, Ilaria Depetris, Tancredi Didier Bazan Russo, Isadora Yasbick Spricido, Camila Bobato Lara Gismondi, Francesco Massari, Nicola Pavan, Matteo Santoni, Tarek Taha   +35 more
wiley   +1 more source